Loading organizations...

§ Private Profile · New York City, NY, USA
Cosmetic dermatology provider offering minimally invasive treatments like Botox, fillers, laser facials, and microneedling for skin rejuvenation.
Based in New York City, Ever/Body is a provider of tech-enabled cosmetic dermatology services that offers minimally invasive medical treatments such as injectables, laser facials, microneedling, and body contouring. The company operates physical clinics supported by proprietary digital booking portals, targeting the broader cosmetic beauty market with a clinical model that sees sixty percent of clients returning for a second service. To support its strategic goal of opening twenty new locations over five years, the enterprise has raised approximately $110 million in total equity funding to date. Recent financing includes a $38 million Series B in 2021 and a $55.5 million Series C round in 2022, backed by notable institutional investors including Addition, Tiger Global, Acme Capital, and Imaginary Ventures. Ever/Body was originally founded in 2018 by Kate Twist, Karen Castelletti, and Maggie Lu.
Ever/Body has raised $111.0M across 3 funding rounds.
Ever/Body has raised $111.0M in total across 3 funding rounds.
Ever/Body has raised $111.0M across 3 funding rounds. Most recently, it raised $56.0M Series C in June 2022.
| Date | Round | Lead Investors | Other Investors | Status |
|---|---|---|---|---|
| Jun 1, 2022 | $56M Series C | Addition | 3VC, Fifth Wall, Picus Capital, Adrian Aoun, ACME Capital, Declaration Partners, Imaginary Ventures, Redesign Health, Tiger Global | Announced |
| May 1, 2021 | $38M Series B | Tiger Global | Fifth Wall, ACME Capital, Addition, Declaration Partners, Gaingels, MetaProp, Redesign Health | Announced |
| Sep 1, 2019 | $17M Series A | ACME Capital | Black Jays Investments, Volition Capital, Dave Gilboa, Jeffrey Raider, Jennifer Fleiss, Joseph Zwillinger, Neil Blumenthal, Declaration Partners, Redesign Health, Tiger Global | Announced |
Ever/Body has raised $111.0M in total across 3 funding rounds.
Ever/Body's investors include Addition, 3VC, Fifth Wall, Picus Capital, Adrian Aoun, ACME Capital, Declaration Partners, Imaginary Ventures, Redesign Health, Tiger Global, Gaingels, MetaProp.
Ever/Body is a cosmetic dermatology company that provides medically-tested, minimally invasive treatments like Botox, wrinkle relaxers, plasma hair restoration, laser hair removal, injectables, and advanced skincare services.[1][2][3][5] It serves a diverse clientele—including all skin tones, textures, ages, genders, BIPOC, and LGBTQ+ communities—by solving the problem of inconsistent, non-inclusive aesthetic care through personalized plans, rigorous provider training, and a seamless digital experience blending medical expertise with medspa luxury.[2][3][5] Founded in 2018 and headquartered in New York, the company has raised $110.75M in funding (latest Series C of $55.5M three years ago), operates clinics in New York City and Washington DC, and shows growth via expansion and proprietary EMR technology.[1][4][5]
Ever/Body was founded in 2018 in New York, New York, emerging from a vision to disrupt the cosmetic dermatology industry by making high-quality, inclusive treatments accessible.[1][2][3] Key early backers included a $17M Series A in October 2019 led by Acme Capital, with participation from Tiger Global Management, Declaration Partners, Redesign Health, and strategics like Warby Parker founders Neil Blumenthal and Dave Gilboa, Rent the Runway's Jenny Fleiss, Harry's co-founder Jeff Raider, and Allbirds' Joey Zwillinger.[2] CEO Kate Twist has highlighted the company's focus on millennials, avoiding "Instagram face" aesthetics, with pivotal moments like launching proprietary training programs and EMR tech for personalized care amid industry gaps in standardization.[2][3][4] Early traction built on blending dermatology's medical rigor with medspa convenience, expanding to multiple locations.[1][5]
Ever/Body rides the digital health and aesthetics tech wave, part of the $11,000+ company sector transforming healthcare via software, platforms, and tech-enabled services like personalized EMR and client apps—excluding pure pharma or hardware.[1] Timing aligns with rising demand for inclusive beauty post-2018, fueled by millennial/gen-Z preferences for transparent, non-invasive treatments amid market forces like medspa proliferation and underserved demographics seeking science-driven care.[2][4] It influences the ecosystem by setting training/EMR standards, attracting VC from tech crossovers (e.g., Warby Parker, Allbirds founders), and normalizing tech-infused dermatology, potentially scaling via clinic growth and digital tools.[1][2]
Ever/Body is poised for expansion with its $110M+ war chest, likely adding locations beyond NYC/DC and refining EMR/website for virtual consultations or at-home integrations.[1][2][5] Trends like AI-personalized skincare, inclusive beauty tech, and subscription models will shape it, amplifying growth in a $15B+ U.S. aesthetics market.[4] Influence may evolve toward platform leadership, exporting training/tech to partners, solidifying its role as the inclusive pioneer that started by making expert dermatology work for *every* body.[2][3]